Zhongchao (ZCMD) Non-Current Deffered Revenue (2018 - 2021)
Zhongchao (ZCMD) reported Non-Current Deffered Revenue of $1127.0 for Q2 2021, down 99.66% on a QoQ basis from $327249.0 in Q4 2018.
Zhongchao (ZCMD) has 2 years of Non-Current Deffered Revenue data on file, last reported at $1127.0 in Q2 2021.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $1127.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $1127.0 (changed N/A YoY) and the FY2018 annual result came in at $327249.0, changed N/A from the prior year.
- Non-Current Deffered Revenue retreated to $1127.0 in Q2 2021 per ZCMD's latest filing, from $327249.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $327249.0 in Q4 2018 and bottomed at $1127.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 4.57 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 400,000.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 5.16 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 10.14 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 63.07 Mn |
| 10 | Zhongchao | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1,127.00 |
| Dec 31, 2018 | 327,249.00 |